• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMERIEUX SA VIDAS® TPSA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMERIEUX SA VIDAS® TPSA Back to Search Results
Catalog Number 30428
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Event Description
A customer in (b)(6) reported a falsely over-estimated result when testing three patient samples in association with vidas® tpsa (total prostate specific antigen) lot 1006670400.The initial test results were reported to the clinician and did not match the clinical status of the patients, so retesting was requested.It was reported that repeat tests were performed in the same day but not in the same time and section of the instrument.It was noted that these tests were performed after expiration date of calibration.The last calibration was performed on (b)(6) 2018 and was conforming on (b)(6) 2018.The internal quality control c1 was conforming.The customer tested also new samples from the patients.Patient 1: first test: 30.04 ng/ml, second test: 0.49 ng/ml, new sample: 0.6 ng/ml.Patient 2: first test: 0.61 ng/ml, second test: 4.63 ng/ml, new sample: 4.78 ng/ml.Patient 3: first test: 0.56 ng/ml, second test: n/a - lack of sample, new sample: 22.31 ng/ml.There is no indication or report from the hospital or treating physician to biomérieux that the discrepant result led to any adverse event related to the patient's state of health.A biomérieux internal investigation will be initiated.
 
Manufacturer Narrative
An internal investigation was performed for falsely over-estimated results when testing three patient samples in association with vidas® tpsa (total prostate specific antigen) lot 1006670400.The analysis of the batch history records for vidas tpsa ref 30428 lot 1006670400/190623-0 showed no anomaly during the manufacturing , control and packaging processes, nor non-conformity linked to customer's issue.The complaint trend analysis confirmed there was no other complaint about not reproducible results on vidas tpsa ref 30428 lot 1006670400/190623-0 control charts analysis observed seven internal samples (target : 0.42- 26.70-4.86-0.38-4.42-20.80-4.74 ng/ml) on seven different batches of vidas tpsa ref 30428 including the customer's lot 1006670400/190623-0.The analysis of the control charts showed that all results are within specifications, and the customer's lot is in the trend of the other lots.The customer's samples were not submitted for evaluation.The complaint laboratory tested three internal samples with the retain kit vidas tpsa ref 30428 lot 1006670400/190623-0.Results from the first test and second test after three days were all within specification.An internal sample was tested with spr (solid phase receptacle) vidas fpsa , and strip vidas tpsa with results of 28.57 ng/l and 2.14 ng/l.The use of a fpsa spr instead of a tpsa spr could explain a decrease of concentration.In conclusion, the root cause was not identified as the samples were not received from the customer.Without samples it was not possible to pursue further investigation.If the operator uses a fpsa spr instead of a tpsa spr, there could be a decrease of concentration.Vidas tpsa ref 30428 lot 1006670400/190623-0 is within the expected performances.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VIDAS® TPSA
Type of Device
VIDAS® TPSA
Manufacturer (Section D)
BIOMERIEUX SA
chemin de l orme
marcy l etoile, rhone 69280,
FR 
MDR Report Key8273897
MDR Text Key135914956
Report Number8020790-2019-00004
Device Sequence Number1
Product Code LTJ
Combination Product (y/n)N
PMA/PMN Number
K010550
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 03/07/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/24/2019
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/23/2019
Device Catalogue Number30428
Device Lot Number1006670400
Was Device Available for Evaluation? No
Date Manufacturer Received02/05/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-